Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Harrison, David J*" or (type exact bookEditor and editor="Harrison, David J*")

Add to list
Epigenetic sampling effects : nephrectomy modifies the clear cell renal cell cancer methylome

Christophe Van Neste (UGent) , Alexander Laird, Fiach O’Mahony, Wim Van Criekinge (UGent) , Dieter Deforce (UGent) , Filip Van Nieuwerburgh (UGent) , Thomas Powles, David J Harrison, Grant D Stewart and Tim De Meyer (UGent)

(2017) CELLULAR ONCOLOGY. 40(3). p.293-297
Add to list
- Journal Article
- A1
- open access
Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer

Grant D Stewart, Thomas Powles, Christophe Van Neste (UGent) , Alison Meynert, Fiach O'Mahony, Alexander Laird, Dieter Deforce (UGent) , Filip Van Nieuwerburgh (UGent) , Geert Trooskens (UGent) , Wim Van Criekinge (UGent) , et al.

(2016) ONCOTARGET. 7(18). p.25241-25250
Add to list
- Conference Paper
- C3
Combined DNA-methylation intensity and clinical risk score to stratify patients for high-grade disease

Leander Van Neste, Grant Stewart, Sandra Marlene Gaston, William E Grizzle, George W Adams, Gary P Kearney, Jonathan I Epstein, David James Harrison, Alan W Partin and Wim Van Criekinge (UGent)

(2016) J. Clin. Oncol.. In JOURNAL OF CLINICAL ONCOLOGY 34(2, suppl.).
Add to list
- Journal Article
- A1
- open access
Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies

Leander Van Neste, Alan W Partin, Grant D Stewart, Jonathan I Epstein, David J Harrison and Wim Van Criekinge (UGent)

(2016) PROSTATE. 76(12). p.1078-1087
Add to list
- Conference Paper
- C3
Risk stratification of aggressive prostate cancer based on combined epigenetic and clinical data of men with initial cancer-negative biopsies

Alan W Partin, Leander Van Neste, Grant D Stewart, Joseph Bigley, David J Harrison, Wim Van Criekinge (UGent) and Jonathan I Epstein

(2015) JOURNAL OF UROLOGY. 193(4, suppl.). p.E959-E960
Add to list
- Conference Paper
- C3
Effect of sunitinib treatment on mutations and methylation in metastatic renal cancer

Grant Stewart, Christophe Van Neste (UGent) , Alison Meynert, Colin Semple, Finch O'Mahony, Alexander Laird, Alan Mackay, Geert Trooskens (UGent) , Wim Van Criekinge (UGent) , Tim De Meyer (UGent) , et al.

(2015) JOURNAL OF CLINICAL ONCOLOGY. 33(7, suppl.).
Add to list
Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study

Grant D Stewart, Leander Van Neste (UGent) , Philippe Delvenne, Paul Delrée, Agnès Delga, S Alan McNeill, Marie O'Donnell, James Clark, Wim Van Criekinge (UGent) , Joseph Bigley, et al.

(2013) JOURNAL OF UROLOGY. 189(3). p.1110-1116
Add to list
The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancer

Kevin Sharpe, Grant D Stewart, Alan Mackay, Christophe Van Neste (UGent) , Charlotte Rofe, Dan Berney, Irfan Kayani, Axel Bex, Elaine Wan, Fiach C O'Mahony, et al.

(2013) CLINICAL CANCER RESEARCH. 19(24). p.6924-6934
Add to list
- Conference Paper
- C3
Prediction of risk for prostate cancer in histopathologically negative biopsies by multigene epigenetic assay

Leander Van Neste, Wim Van Criekinge (UGent) , Olivier Thas (UGent) , Joseph Bigley, Grant Duncan Stewart and David James Harrison

(2013) JOURNAL OF CLINICAL ONCOLOGY. 31(6, suppl.).

Academic Bibliography

Epigenetic sampling effects : nephrectomy modifies the clear cell renal cell cancer methylome

Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer

Combined DNA-methylation intensity and clinical risk score to stratify patients for high-grade disease

Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies

Risk stratification of aggressive prostate cancer based on combined epigenetic and clinical data of men with initial cancer-negative biopsies

Effect of sunitinib treatment on mutations and methylation in metastatic renal cancer

Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study

The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancer

Prediction of risk for prostate cancer in histopathologically negative biopsies by multigene epigenetic assay

Contents

Support

Contact